Immunohistochemical and quantitative mRNA assessment of ghrelin expression in gastric and oesophageal adenocarcinoma

Journal of Clinical Pathology

Volumn 60, Issue 4, 2007, Pages 405-409

  Mottershead, Marcus ^a   Karteris, Emmanuel ^b   Barclay, Jill Y ^b   Suortamo, Saira ^a   Newbold, Mark ^a   Randeva, Harpal ^b   Nwokolo, Chuka U ^a  

^a UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; MESSENGER RNA;

ARTICLE; CARDIA; DATA BASE; ESOPHAGEAL ADENOCARCINOMA; HORMONE RELEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; ESOPHAGEAL NEOPLASMS; GASTRIC MUCOSA; HUMANS; IMMUNOENZYME TECHNIQUES; NEUROSECRETORY SYSTEMS; PEPTIDE HORMONES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; STOMACH NEOPLASMS;

EID: 34247101063     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2006.038356     Document Type: Article

References (37)

1. Liberman DA, Oehike M, Helfand M. Risk factors for Barrett's oesophagus in community based practice GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy. Am J Gastroenterol 1997;92:1293-7.
2. Allum WH, Griffin SM, Watson A, et al. Guidelines for the management of oesophageal and gastric cancer. Gut 2002;50(Suppl 5):v1-23.
3. Grimble RF. Nutritional therapy for cancer cachexia. Gut 2003;52:1391-2.
4. Puccio M, Nathanson L. The cancer cachexia syndrome. Semin Oncol 1997;24:277-87.
5. MacDonald N, Easson AM, Mazurak VC, et al. Understanding and managing cancer cachexia. J Am Coll Surg 2003;197:143-61.
6. Falconer JS, Fearon KC, Plester CE, et al. Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg 1994;219:325-31.
7. Hyltander A, Drott C, Korner U, et al. Elevated energy expenditure in cancer patients with solid tumours. Eur J Cancer 1991;27:9-15.
8. Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone releasing acylated peptide from stomach. Nature 1999;402:656-60.
9. Gualillo O, Lago O, Gomez-Reino J, et al. Ghrelin, a widespread hormone: insights into molecular and cellular regulation of its expression and mechanism of action. FEBS Lett 2003;552:105-9.
10. Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001;86:5992-5.
11. Wren AM, Small CJ, Abbott CR, et al. Ghrelin causes hyperphagia and obesity in rats. Diabetes 2001;50:2540-7.
12. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000;407:908-13.
13. Nakazato M, Murakami N, Date Y, et al. A role for ghrelin in the central regulation of feeding. Nature 2001;409:194-8.
14. Date Y, Kojima M, Hosoda H, et al. A novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000;141:4255-61.
15. Rindi G, Neechi V, Savio A, et al. Characterisation of gastric ghrelin cells in man and other mammals: studies in adult and foetal tissues. Histochem Cell Biol 2002;117:511-19.
16. Sakata I, Nakamura K, Yamazaki M, et al. Ghrelin-producing cells exist as two types of cells, closed- and opened-type cells, in the rat gastrointestinal tract. Peptides 2002;23:531-6.
17. Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric surgery. N Engl J Med 2002;346:1623-30.
18. Ariyasu H, Takaya K, Tagami T, et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 2001;86:4753-8.
19. Takaya K, Ariyasu H, Kanamoto N, et al. Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 2000;85:4908-11.
20. Bowers CY. Unnatural growth hormone-releasing peptide begets natural ghrelin. J Clin Endocrinol Metab 2001;86:1464-9.
21. Arvat E, DiVito L, Broglio F, et al. Preliminary evidence that ghrelin the natural GH secretogogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J Endocrinol Invest 2000;23:493-5.
22. Peino R, Baldelli R, Rodriguez-Garcia J, et al. Ghrelin-induced growth hormone secretion in humans. Eur J Endocrinol 2000;143:R11-14.
23. Kojima M, Hosoda H, Matsuo H, et al. discovery of the natural endogenous ligand for the growth hormone secretogogue receptor. Trends Endocrinol Metab 2001;12:118-22.
24. Cummings DE, Purnell JQ, Frayo RS, et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001;50:1714-19.
25. Tschop M, Wawarta R, Riepl RL, et al. Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest 2001;24:RC19-21.
26. Asakawa A, Inui A, Kaga T, et al. Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut 2003;52:947-52.
27. Kohno D, Gao HZ, Muroya S, et al. Ghrelin directly interacts with neuropeptide-Y containing neurons in the rat arcuate nucleus: Ca2+ signalling via protein kinase A and N-type channel-dependent mechanisms and cross-talk with leptin and orexin. Diabetes 2003;52:948-56.
28. Date Y, Murakami N, Toshinai K, et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 2002;123:1120-8.
29. Korbonits M, Bustin SA, Kojima M, et al. The expression of the growth hormone secretogogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors. J Clin Endocrinol Metab 2001;86:881-7.
30. Corbetta S, Peracchi M, Cappiello V, et al. Circulating ghrelin levels in patients with pancreatic and gastrointestinal neuroendocrine tumors: identification of one pancreatic ghrelinoma. J Clin Endocrinol Metab 2003;88:3117-20.
31. Papotti M, Cassoni P, Volante M, et al. Ghrelin-producing endocrine tumours of the stomach and intestine. J Clin Endocrinol Metab 2001;86:5052-9.
32. Rindi G, Savio A, Torsello A, et al. Ghrelin expression in gut endocrine growths. Histochem Cell Biol 2002;117:521-5.
33. Aydin S, Ozercan IH, Dagli F, et al. Ghrelin immunohistochemistry of gastric adenocarcinoma and mucoepidermoid carcinoma of the salivary gland. Biotech Histochem 2005;80:163-8.
34. Gualillo O, Caminos J, Blanco M, et al. a novel placental-derived hormona. Endocrinology 2001;142:788-94.
35. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45.
36. Suzuki H, Masaoka T, Hosoda H, et al. Helicobacter pylori infection modifies gastric and plasma ghrelin dynamics in Mongolian gerbils. Gut 2004;53:187-94.
37. Shimizu Y, Nagaya N, Isobe T, et al. Increased plasma ghrelin level in lung cancer cachexia. Clin Cancer Res 2003;9:774-8.